ADC Therapeutics SA announced the appointment of Victor Sandor, M.D., to its Board of Directors. Dr. Sandor was most recently Chief Medical Officer at Array BioPharma Inc. prior to its acquisition by Pfizer Inc. At Array, Dr. Sandor was instrumental in obtaining the approval of Braftovi® (encorafenib) and Mektovi® (binimetinib).